Arbutus Biopharma Corporation · NASDAQ:ABUS

Roivant Sciences Ltd. reported a 19.50% stake in Arbutus Biopharma Corporation (Schedule 13D/A)

Event Oct 1, 2026 · Filed Oct 5, 2026

Roivant Sciences Ltd. reported a 19.50% stake in Arbutus Biopharma Corporation, 29,880,079 shares, with active intent on Oct 1, 2026. Filed Oct 5, 2026 (Schedule 13D/A).

Stake
19.50%
Shares
29,880,079
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Roivant Sciences Ltd.19.50%29,880,079

Source

View original at SEC

Related